Stoked Bio is creating the path of least resistance by reimagining how therapies for drug-resistant infections and cancer are discovered. Our biology-first platform integrates proprietary, disease-specific training data with machine learning to identify compounds with real biological effect, not just statistical noise. By increasing the odds of success, we can accelerate timelines through early pharma partnerships to deliver strong near-term investor value. Our portfolio continues to expand with novel therapeutic options to treat important resistant diseases.